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Novel Mutations in ALOX12B in Patients with
Autosomal Recessive Congenital Ichthyosis
and Evidence for Genetic Heterogeneity
on Chromosome 17p13
Fabienne Lesueur1, Bakar Bouadjar2, Caroline Lefe`vre1, Florence Jobard1, Ste´phanie Audebert1,
Hakima Lakhdar3, Ludovic Martin4, Gianluca Tadini5, Aysen Karaduman6, Serap Emre7, Safa Saker8,
Mark Lathrop1 and Judith Fischer1
We report clinical and molecular findings in 20 patients from 11 families with autosomal recessive congenital
ichthyosis (ARCI) linked to chromosome 17p13, and attributed to mutations in the ALOX gene cluster, which
includes three lipoxygenase genes, ALOXE3, ALOX12B, and ALOX15B. We identified six novel missense
mutations and one novel deletion leading to a premature stop codon in ALOX12B in only six out of the 11
families which led us to investigate a possible implication of ALOX15B. Mutation analysis of this gene, as well as
ALOXE3, which is known to be mutated in some cases of ARCI, failed to reveal causative mutations in the five
remaining ARCI families, indicating that other genes on chromosome 17p13 may be involved in this disease.
However, by adding new variants to the repertoire of ALOX12B mutations in non-bullous congenital
ichthyosiform erythroderma, our data contribute to an enlargement of the spectrum of mutations for the
development of efficient molecular genetic tests for analysis of at risk individuals whose carrier status is
unknown.
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INTRODUCTION
Autosomal recessive congenital ichthyosis (ARCI) is a
clinically and genetically heterogeneous group of disorders
of keratinization characterized by skin desquamation over the
whole body, often associated with erythema (Williams and
Elias, 1985; Traupe, 1989). It is a severe condition with an
estimated prevalence of one in 300,000 newborns and most
of the patients are born as collodion babies. To date, six
genes for ARCI have been identified, TGM1 (MIM 242300)
on chromosome 14q11 (Huber et al., 1995; Russell et al.,
1995), ABCA12 (MIM 601277) on chromosome 2q34–q35
(Lefe`vre et al., 2003), ichthyin on chromosome 5q33 (Lefe`vre
et al., 2004), ALOXE3 and ALOX12B (MIM242100) on
chromosome 17p13 (Jobard et al., 2002) and CYP4F22
(MIM 604777) on chromosome 19p12–q12 (Fischer et al.,
2000; Lefe`vre et al., 2006). Furthermore, two additional loci
have been described, the first on chromosome
19p13.2–p13.1 (MIM604781) (Virolainen et al., 2000) which
probably corresponds to the gene CYP4F22 and the second
on chromosome 12p11.2–q13 (Mizrachi-Koren et al., 2005).
In addition, mutations in CGI-58/ABHD5 on chromosome
3p21 (MIM 275630) have been found to underlie Chanarin–
Dorfman syndrome, a form of syndromic congenital ichthyo-
sis with non-cutaneous characteristics involving liver, eyes,
muscles, and nerves (Lefe`vre et al., 2001).
In 2002, we identified mutations in the genes ALOX12B
and ALOXE3, in patients with non-bullous congenital
ichthyosiform erythroderma from the Mediterranean area
(Jobard et al., 2002). These two genes encode the epidermal
lipoxygenases 12R-lipoxygenase (12R-LOX) and lipoxygen-
ase 3 (eLOX3). They are part of the LOX gene cluster of
approximately 100 kb, which also contains the ALOX15B
gene and the ALOX15P pseudogene. The ALOX15B gene,
which encodes the 15S-lipoxygenase (15S-LOX-2), is located
in the same orientation 25 kb downstream of ALOX12B and
consists of 14 exons that are distributed over 9.7 kb of
genomic sequence. Its involvement in ARCI has not been
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investigated so far. In this study, we report mutation analysis
of the ALOXE3, ALOX12B, and ALOX15B genes in a total of
20 patients from 11 families.
RESULTS
All 20 patients were diagnosed as having ARCI based on
common clinical criteria and had unaffected parents. The
families were from Algeria, Italy, Morocco, Spain, Tunisia,
and Turkey; nine of the 11 families were consanguineous.
Most patients exhibited palmoplantar keratoderma with
fissures, especially on the heel, and ichthyotic scaling of
the scalp. The clinical details are presented in Table 1.
We excluded known loci on chromosomes 2, 3, 5, 12, 14,
and 19 by genotyping and haplotype analysis in all the
families reported here. Genotyping results in the consangui-
neous ARCI families I to VII showed homozygous haplotypes
at the 17p13.1 locus defined by D17S1353, D17S1796,
D17S1812, and D17S1805 for all patients except for family
VIII in which a recombination was observed between
D17S1812 and D17S1805 (Figure 1a). The genes ALOX15B,
ALOX12B and ALOXE3 are situated between the markers
D17S1796 and D17S1812.
For the eight kindreds, mutation screening was performed
in one affected child per family in which a homozygous
haplotypes segregated. Sequencing of the 15 exons of
ALOXE3, 15 exons of ALOX12B, and the exon–intron
boundaries of the two genes revealed four variations in the
coding sequence of the ALOX12B gene and two variations in
the coding sequence of the ALOXE3 gene (Table 2). The
missense variations at codon 360, at codon 527, and a 2 bp
deletion at codon 211, resulting in a premature stop codon at
codon 239 in ALOX12B, appeared to be true mutations, as all
affected children in the consanguineous families II, III, and IV
were homozygous for those mutations and none of these
novel sequence variations were found in 52 unrelated controls
from North Africa. However, the variant P127S in ALOX12B,
already reported by others as a mutation (Eckl et al., 2005),
and the variants I515V and R670W in ALOXE3, are likely to
Table 1. Clinical features
Family I II IV VI VII IX X XI
Mutation No ALOX12B ALOX12B No No ALOX12B ALOX12B ALOX12B
Collodion
baby
No No No No Yes Yes Yes Yes
Erythroderma Yes Yes Yes No Yes Yes Mild Mild
Type of
ichtyosis
now
NCIE NCIE NCIE Lamellar NCIE NCIE NCIE Lamellar
Type of
scales
Fine,
pigmented,
larger on
legs and
arms
Fine, white
on thorax;
large brown
polygonal
on the legs
Fine, white Gray
polygonal,
xerosis of the
skin
Fine,
pigmented
Large brown Mild
scaling
Intense
lamellar
scaling,
xerosis
Site Whole body,
more severe
on legs and
arms
Whole body,
more severe
on legs
Whole body,
legs more
severe on
legs
Whole body
including folds,
face, scalp
Mainly arms
and legs
Whole body
including face
Whole body Whole body,
more severe
on face and
legs; xerosis
on trunk and
folds
Scalp Extensive
ichthyotic
scaling
Extensive
ichthyotic
scaling
Extensive
ichthyotic
scaling
Ichthyotic
scaling
Ichthyotic
scaling
Mild Mild scaling No
Palmoplantar
keratoderma
No Yes, with
fissures
(heel)
Yes, with
fissures
(heel)
Hyperstriation
of palmo-
plantar, knees,
fingers
Yes, with
fissures
(heel)
Yes, severe with
fissures
Hyperlinearity
and scaling
Hyperkeratosis
and
hyperlinearity
Remarks Longitudinal
striation of
nails
Longitudinal
striation of
nails
Photosensibility Convex nails,
small stature
Light
Photosensibility
Histology ND Hyper and
orthokeratosis;
absence of
stratum
granulosum
Hyper and
orthokeratosis;
reduced
stratum
granulosum
Hyper and
orthokeratosis,
keratohyaline
inclusions;
abnormal
stratum
granulosum
Hyper and
orthokeratosis;
reduced stratum
granulosum
ND ND ND
NCIE, non-bullous congenital ichthyosiform erythroderma; ND, no data.
No clinical data were available for families III, V, and VIII.
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represent rare single nucleotide polymorphisms (SNPs) as they
have been found at a frequency of 4, 1, and 6%, respectively,
in controls from North Africa (Table 2). The SNP I515V in
ALOXE3 is reported in the dbSNP database as SNP rs3027205.
ALOXE3 and ALOX12B are part of the LOX gene cluster
within a genomic segment of 100 kb at 17p13.1 (Krieg et al.,
2001). This cluster contains a third gene of the epidermis-type
LOX family, ALOX15B, which is highly expressed in skin as
well. The ALOX15B transcript (NM_00141) exhibits 92%
identity with ALOXE3 (NM_021628) and 78% identity with
ALOX12B (NM_001139). Because no causative mutations
in ALOXE3 and ALOX12B were found in families I, V, VI,
VII, and VIII, and because ALOX15B represents a strong
candidate gene, we performed mutation screening in this
gene in these five ARCI families. No mutations in the coding
sequence and at the splice junctions of ALOX15B were found
in the affected members of these families.
During the course of the study, three ARCI families from
Algeria (family IX), Italy (family X), and Turkey (family XI) were
identified (Figure 1b). Haplotypes analysis suggested linkage to
chromosome 17p13 and excluded linkage to all other known
loci on chromosomes 2, 3, 5, 12, 14, and 19. We undertook
mutation screening in the LOX genes for those patients as well
(Table 2). Of the two affected sisters in family IX, one died at
birth and no material was available for genetic study. The
second child was heterozygous for the 2 bp deletion in exon 5
of ALOX12B found previously in family II. Having sequenced
all exons and the exon–intron boundaries of the gene, we
could not find a second mutation in this patient.
Mutation analysis carried out in ALOX12B in family X
from Italy revealed three novel compound mutations leading
to amino-acid changes: the two affected sisters (right branch
of family X, Figure 1b) had inherited the mutation H421Y
from their father and the mutation Q538P from their mother.
Their affected cousin (left branch of family X) carried the
same mutation H421Y, inherited from her mother and a new
mutation, R679S, inherited from her father. A mutation at
codon 679 had been previously reported by others in an ARCI
patient, but the sequence variation occurred in a different
base of the codon, changing an arginine to leucine instead of
serine (Eckl et al., 2005). A sixth novel non-synonymous
mutation was found in consanguineous family XI at codon
394 (E394K) (Table 2). None of these mutations were present
in the 52 unrelated controls from North Africa.
DISCUSSION
By adding new variants to repertoire of ALOX12B mutations
in non-bullous congenital ichthyosiform erythroderma, our
data contribute to an enlargement of the spectrum of
mutations for the development of efficient molecular genetic
tests for analysis of at risk individuals whose carrier status is
unknown. The clinical descriptions of patients (Table 2) did
not permit a correlation between mutations in ALOX12B
(Table 1) and a specific ARCI phenotype.
This is also the first study in which a possible role of
ALOX15B in ARCI has been investigated. We were able to
exclude the involvement of this candidate gene as well as of
ALOXE3 and ALOX12B in five ARCI families, indicating that
the disease in these families must be caused by mutations
in other genes inside the interval on chromosome 17p13.
Haplotype analyses in the first eight families (I–VIII) provide
strong evidence for the presence of a predisposing gene at
Table 2. Mutations and polymorphisms in the ALOX12B and ALOXE3 genes in ARCI families
Family
Nb of
affected Origin Consanguinity Nucleotide change1 Site Effect
Variation
type2
I 1 Algeria + ALOX12B: c.[379 C4T] [=]+[=] Exon 3 P127S SNP (4%)
II 1 Algeria + ALOX12B: c.[632_633 delTC] [=]+[=] Exon 5 F211CfsX29 Mutation
III 1 Morocco + ALOX12B: c.[1078 C4G] [=]+[=] Exon 9 Q360E Mutation
IV 2 Algeria + ALOX12B: c.[1579 G4A] [=]+[=] Exon 12 V527M Mutation
V 1 Algeria + ALOXE3: c.[1543 A4G]+[=] Exon 11 I515V SNP (1%)3
VI 4 Tunisia + ALOXE3: c.[2008 C4T] [=]+[=] Exon 15 R670W SNP (6%)
VII 1 Algeria + — — — —
VIII 1 Spain + — — — —
IX 2 Algeria  ALOX12B: c.[632_633 delTC]+[=] Exon 5 F211CfsX29 Mutation
X right branch4 2 Italy  ALOX12B: c.[1261 C4T]+[1613 A4C] Exon 9, exon 12 H421Y
Q538P
Mutation
Mutation
X left branch4 1 Italy  ALOX12B: c.[1261 C4T]+[2035 C4A] Exon 9, exon 15 H421Y
R679S
Mutation
Mutation
XI 3 Turkey + ALOX12B: c.[1180 G4A] [=]+[=] Exon 9 E394K Mutation
ARCI, autosomal recessive congenital ichthyosis.
1According to the nomenclature of sequence variations, as provided by the Human Genome Variation Society (www.hgvs.org). (position 1=start codon).
[=]+[=], the patient is homozygous for the variant; +[=], the patient is heterozygous for the variant.
2When the variation is a polymorphism, its frequency in the North African population is indicated in parentheses.
3rs3027205 in dbSNP database.
4See pedigree X in Figure 1b.
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this locus. However, we have found causative mutations in
only three families, despite the informativeness of families V,
VI, and VII. It is possible that the patients in the small
consanguineous families with only one affected individual
show homozygous haplotypes by chance, and the possibility
of a linkage to a different locus cannot be formally excluded.
Although unlikely, it is possible that patients of families I, V,
VI, VII, VIII, and IX carry intronic mutations creating cryptic
splice sites, or a mutation in the regulatory elements which
might alter the expression of the proteins. One alternative
hypothesis to explain possible linkage to this locus, as
suggested by the haplotype analysis, would be the presence
of another gene involved in predisposition to the disease in
the same interval. To date, seven known genes have been
characterized between D17S1353 and D17S1796, 20 genes
between D17S1796 and D17S1812, and five genes between
D17S1812 and D17S1805.
The affected child in consanguineous family I was
homozygous for the variant P127S in ALOX12B, and the
affected child in family VI was homozygous for the variant
R670W in ALOXE3, and in both cases the unaffected parents
were found to be heterozygous for the variant. We believe
that it is quite unlikely that these sequence variations
constitute the causative mutations as they were found to have
a frequency of 4 and 6%, respectively, in the North African
control population. However a recent report described a self-
healing collodion baby of Turkish origin, who was hetero-
zygous for the variant P127S in ALOX12B and for which a
second mutation was not found (Eckl et al., 2005). The authors
postulated that this variant was responsible for the instability
of the protein in the mutant cells and the lack of expression of
the protein. Our findings would suggest that, if confirmed, this
dysfunction of ALOX12B would be due to another unknown
mutation rather than to the SNP P127S itself.
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Figure 1. ARCI pedigrees. (a) Pedigrees and construction of haplotypes in the eight ARCI families used for haplotype analysis. Blackened symbols denote ARCI
patients. Position of the markers from the p telomere of chromosome 17 from Golden Path (http://genome.ucsc.edu): D17S1353 at 7.55 Mb; D17S1796 at
7.73 Mb; D17S1805 at 8.52 Mb; and D17S1818 at 34.42 Mb. Affected haplotypes are boxed. (b) Pedigrees of the three recently identified ARCI families included
in the mutation-screening panel. *Individual in which mutation analysis was performed. (Figure 1 continued on following page.)
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Identification of seven novel mutations in ALOX12B in
families from Algeria, Italy, Morocco, and Turkey brings the
total number of reported mutations in this gene to 20; seven
point mutations have been reported in ALOXE3 (Jobard et al.,
2002; Eckl et al., 2005). The patient in family IX was
heterozygous for the c632_633 delTC mutation and we did
not find a second mutation in another exon of the gene. It is
unlikely that this variation corresponds to a rare polymorph-
ism as it has been found in the homozygous state in family II,
and was not present in the 52 controls (104 chromosomes)
from North Africa that were sequenced. A more plausible
explanation would be the presence of a second undetected
mutation within the intronic sequence creating a cryptic
splice site, or within the regulatory sequences leading to a
lack of expression of the protein. The possibility of a large
deletion, which would be undetectable when sequencing the
exonic regions separately, cannot not be discounted either.
Recently, Yu et al. (2005) have shown that the previously
reported mutations in the ALOXE3 and ALOX12B genes
completely eliminate the enzymatic activities of the two
epidermal lipoxygenases. Although we have not analyzed the
biochemical effect of the novel ALOX12B mutations pre-
sented here, we can postulate that they also have deleterious
consequences on enzyme function: the deletion c632_633
delTC leads to a premature stop codon upstream from the
lipoxygenase activity domain. The six missense mutations
Q360E, E394K, H421Y, V527M, Q538P, and R679S are all
located within the lipoxygenase catalytic domain, and
amino-acid changes may alter the folding of the protein,
and therefore abolish or alter ALOX12B activity (Figure 2).
Taken together, these genetic and biochemical insights
provide evidence for the involvement of lipoxygenases in
the formation of the skin permeability barrier.
MATERIALS AND METHODS
Genetic analysis
DNA was extracted from whole blood using standard procedures
after informed consent of the patients and/or their parents. The
medical ethical committee of AFM/Ge´ne´thon approved the de-
scribed study. The study was conducted in concordance with the
Declaration of Helsinki Principles. Genotyping using an exclusion
panel of 36 fluorescent microsatellite markers at known loci on
chromosomes 2, 3, 5, 12, 14, 17, and 19 was carried out in families
I–VIII as described previously (Fischer et al., 2000). The set of
*
*
**
*
*
*
*
*
* *
**
Family IX
Family X
Family XI
b
Figure 1. Continued.
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microsatellites used includes markers D17S1353, D17S1796,
D17S1812, and D17S1805 around the epidermis-type LOX gene
cluster. In addition to this panel, a genome-wide scan was performed
on families IX, X, and XI using 430 highly polymorphic microsatellite
markers from the ABI panel (Linkage Mapping Set2, LMS2, Applied
Biosystems, Foster City, CA). Haplotypes were constructed assuming
the most parsimonious linkage phase.
Mutation screening
We sequenced at least one affected individual per family and one or
both parents. Oligonucleotide primers for ALOX12B and ALOXE3
genes flanking the coding exons and internal primers for sequencing
were those described previously (Jobard et al., 2002). Primers and
PCR conditions used for the screening of the ALOX15B gene are
given in the Table S1 available online. Both strands from all subjects
and controls were sequenced for the entire coding region and the
intron–exon boundaries.
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